REKA Health: Mobile Health with High Compliance, Digital Cardiac Rhythm Monitoring Solution & Cardiac Health Insights

Font Size



Menu Style


Deployed in The UK

REKA Health's Solutions Deployed in the UK

Partner with Britain's Largest ECG Interpretation Service Provider Broomwell-Healthwatch

  • Broomwell-Healthwatch will deploy the REKA E100L solution (CE Mark approved) to serve UK’s private market and Britain’s National Health Service network
  • REKA’s solution was chosen for its ease of use and efficient transmission of data, enabling immediate analysis and interpretation of results


United Kingdom, Singapore - 16th March 2015 - Britain’s largest electrocardiogram (ECG) interpretation service Broomwell-Healthwatch Ltd (Broomwell) has deployed Singapore-based REKA Health Pte Ltd (REKA) cardiac monitors and cloud-based solutions to serve both the National Health Service (NHS) Primary Care and private market in the UK to detect arrhythmia.

Broomwell, whose cardiac-physiologists have successfully interpreted over 500,000 ECGs, currently offers mobile ECG recorder units for patients to wear 24-hours a day up to eight days. Broomwell is now expanding its arrhythmia detection offerings to include the E100L Digital Loop Event Monitor by REKA.

Episodes of arrhythmia, a heart condition whereby the heartbeat is irregular, can occur anytime, lasting anywhere between a few minutes to a few hours. The Digital Loop Event Monitor service is a seven-day home monitoring service, offered by Broomwell, to record the ECG of a patient that is experiencing arrhythmia.

The REKA E100L is able to record valuable ECG data before and after an arrhythmia episode experienced by a patient. The data recorded will be uploaded onto REKA’s cloud solution, providing cardiac-physiologists with insights to what triggers each episode. The E100L, which can fit into a pocket giving users mobility outside the hospital, allows users to quickly record an episode anywhere, when necessary.

Supported by REKA’s facility in the Netherlands, Broomwell is deploying REKA’s solution to enhance the operational efficiency of its cardiac professionals. Patients can also use a computer or mobile application to upload ECG recordings which can be immediately interpreted with the aid of online records.

Mr. Joshua Rowe, Chairman of Broomwell, said, ‘Now, we are well equipped with REKA’s solution to expand our services for arrhythmia. Our arrhythmia monitoring will be greatly enhanced by the ease of use and efficient transmission of data, inherent in the REKA system. REKA’s solution enables immediate analysis and interpretation of results by Broomwell’s expert cardiac clinicians.’

Mr. Tan Kae Yuan, CEO of REKA, said, ‘With REKA’s solution being deployed to serve the NHS market, our CE Mark approved E100L can benefit more heart patients in the UK while reducing the healthcare cost burden. We are honoured to support Broomwell for this exciting mobile health opportunity.’

End of Press Release


About Broomwell-Healthwatch Ltd
Broomwell was set up in 2004, to enable every GP practice to offer 12 lead ECG diagnostics in-house via the telephone or computer, providing expert cardiac diagnostics within minutes. Broomwell is one of the largest providers of expert ECG services to the NHS Primary Care. Alongside the 12 lead ECG service, Broomwell’s arrhythmia services are also used by a large number of CCGs. The Broomwell operation does about 3,000 ECGs per week and is available to assist GP surgeries, walk-in centres, MIUs, nursing teams and virtual wards daily.

For more information, visit:
Broomwell-Healthwatch Limited Contact:
86 Prince Street, Manchester M1 6NG,
United Kingdom
This email address is being protected from spambots. You need JavaScript enabled to view it.  


About REKA Health Pte Ltd
REKA Health (REKA) is a leading digital cardiovascular monitoring solution provider for the healthcare professionals and researchers. REKA has developed an easy-to-use solution that complies with medical regulatory standards. The solution comprises medical grade devices, computer and mobile software, and cloud-based web applications that are seamlessly integrated making it the preferred choice by healthcare professionals for their practices and by pharmaceutical companies for their clinical trials. REKA was founded in 2011, headquartered in Singapore with satellite offices in New Jersey, USA and the Netherlands. Marketing under the REKA® brand, REKA has gained recognition from international practitioner communities and has established its global presence covering Europe, North America and Asia Pacific markets.
For more information, visit:

REKA Health Pte Ltd Contact:
2 International Business Park
#11-01/02 The Strategy, Singapore 609930
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Relations Contact
WeR1 Consultants Pte Ltd
38A Circular Road Singapore 049394
Tel: (65) 6737 4844 Fax: (65) 6737 4944
Kohinoor Dev Roy, This email address is being protected from spambots. You need JavaScript enabled to view it.
Benjamin Cher, This email address is being protected from spambots. You need JavaScript enabled to view it.